ArticlePatient preference and adherence2016

Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population.

Tatiana Dilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.